Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Health Canada Approves Moderna COVID Vaccine for Kids 6-11

Stockhouse Editorial
2 Comments| March 18, 2022

{{labelSign}}  Favorites
{{errorMessage}}

This week, Health Canada announced that it had approved the use of Moderna Inc. (NASDAQ: MRNA, Forum) COVID-19 vaccine for children between the ages of six to 11 years old.

The company said last year that its two-dose, messenger RNA (mRNA) vaccine generated virus-neutralizing antibodies in children and safety was comparable to that seen in clinical trials of adolescents and adults.

The dosing schedule approved by Health Canada is to give the two doses — a 100 microgram dose each for ages 12 and older, and a half-dose each for ages six to 11 — one month apart.

Branded Spikevax, the vaccine, was recently cleared for use among kids in the same age group in Australia and the European Union.

Chief Executive Officer of Moderna, Stéphane Bancel explained in the news release that Health Canada was the first regulator to fully approve our COVID-19 vaccine, and we are pleased they have taken this important step to expand this authorization to children. The shot is also approved as a booster dose for adults 18 and up.

The vaccine is already approved in the US for those aged 18 and older. The company is awaiting a decision from regulators to use its vaccine for children aged 12 to 17 years.

Its rival, Pfizer Inc. (NYSE: PFE, Forum) had its COVID-19 shot cleared in the United States for children as young as five years.

Canada authorized Moderna's vaccine for adolescents back in August.


{{labelSign}}  Favorites
{{errorMessage}}

Comments

No comments yet. Be first to comment!

Leave a Comment

You must be logged in to be able to post a comment.

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today